Answers are grounded in this paper and cite their sources.
(1) Phenobarbitone in a dose of 8 mg/kg per day was given in twice-daily intramuscular doses to preterm infants with a gestational age of 36 completed weeks or less. The phenobarbitone was started within the first 24 hours after birth. (2) The peak serum bilirubin levels of these infants and matched, randomly selected, control infants were compared sequentially. A significantly lower (P [unk]0·05) peak bilirubin level was found in the treated group. (3) This lower level of serum bilirubin may be less liable to produce neurological damage in preterm infants.
No takes yet. Share an insight, caveat, or question.
Carswell et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: